Literature DB >> 32173209

Current Practice of Calcium Use During Cardiopulmonary Bypass Weaning: Results of an International Survey.

Vladimir V Lomivorotov1, Dmitri Guvakov2, Alessandro Belletti3, Vladimir Boboshko4, Vladimir Shmyrev4, Gudrun Kunst5, Christian Stoppe6, Boris Akselrod7, Nikolay Kamenshchikov8, Sergey Efremov9, Alexander Chernyavskiy4, Giovanni Landoni10.   

Abstract

OBJECTIVES: To describe international practices on the use of calcium salts during cardiopulmonary bypass (CPB) weaning in adult cardiac surgery patients.
DESIGN: Multiple-choice survey on current practice of CPB weaning.
SETTING: Online survey using the SurveyMonkey platform. PARTICIPANTS: Departments of cardiac anesthesiology worldwide.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Out of 112 surveys sent, 100 centers from 32 countries replied. The majority of centers (88 of 100 = 88%) administer calcium salts intraoperatively: 71 of 100 (71%) are using these drugs for CPB weaning and 78 of 100 (78%) for correction of hypocalcemia. Among the 88 centers that use calcium salts intraoperatively, 66% (58 of 88) of respondents use calcium chloride, 22% (19 of 88) use calcium gluconate, and 12% (11 of 88) use both drugs. Calcium salts are routinely used during normal (47 of 71 centers = 66%) and difficult (59 of 71 centers = 83%) weaning from CPB. Doses of 5 to 15 mg/kg during termination of CPB were used by 55 of 71 centers (77%) either by bolus (39 of 71, 55%) or over a time period longer than 1 minute (32 of 71 = 45%). Norepinephrine is the most commonly used first line vasopressor or inotropic agent used to support hemodynamics during termination of CPB in 32 out of 100 centers (32%), and calcium is the second one, used by 23 out of 100 centers (23%).
CONCLUSION: This survey demonstrates that the majority of cardiac centers use calcium in adult patients undergoing cardiac surgery, especially during weaning from CPB. There is variability on the type of drug, dose, and modality of drug administration.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anesthesia; calcium; cardiac anesthesia; intensive care; international survey; weaning from cardiopulmonary bypass

Mesh:

Substances:

Year:  2020        PMID: 32173209     DOI: 10.1053/j.jvca.2020.02.010

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  2 in total

1.  Calcium administration In patients undergoing CardiAc suRgery under cardiopulmonary bypasS (ICARUS trial): Rationale and design of a randomized controlled trial.

Authors:  Vladimir Lomivorotov; Dmitry Ponomarev; Vladimir Boboshko; Vladimir Shmyrev; Samandar Ismoilov; Sergey Efremov; Nikolay Kamenshchikov; Boris Akselrod; Vadim Pasyuga; Dmitry Urusov; Alexey Ovezov; Mikhail Evdokimov; Alexander Turchaninov; Alexander Bogachev-Prokofiev; Nazar Bukamal; Sarah Afifi; Alessandro Belletti; Rinaldo Bellomo; Giovanni Landoni
Journal:  Contemp Clin Trials Commun       Date:  2021-08-18

2.  The effect of calcium gluconate administration during cardiopulmonary bypass on hemodynamic variables in infants undergoing open-heart surgery.

Authors:  Seyedeh Zahra Faritous; Saeed Rajabzade Zaree; Zohreh Morshedizad; Amir Hossein Jalali; Soha Mehrabi Mahani; Maziar Gholampour
Journal:  Egypt Heart J       Date:  2022-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.